Back
Global X Intermediate-Term Trsy Lddr ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
1
MLDR
Global X Intermediate-Term Trsy Lddr ETF
Last Price:
50.00
Seasonality Move:
--
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
32.24
Seasonality Move:
18.8%
Sell
1
Global X Intermediate-Term Trsy Lddr ETF (MLDR)
is a Sell
Is Global X Intermediate-Term Trsy Lddr ETF a Buy, Sell or Hold?
- The current Global X Intermediate-Term Trsy Lddr ETF [MLDR] share price is $50.13. The Score for MLDR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- MLDR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MLDR Stock Price Chart
What is Global X Intermediate-Term Trsy Lddr ETF's stock price today?
-
The Global X Intermediate-Term Trsy Lddr ETF share price today is $50.13
The current trend is relatively stagnant and MLDR is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
MLDR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.92 | Buy |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 33.6 | Sell |
Chaikin Money Flow: | -1084788 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.37 - 40.01) | Sell |
Bollinger Bands (100): | (36.55 - 42.35) | Sell |
MLDR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.2 | Sell |
20-day SMA: | 0 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 43.45 | Buy |
20-day EMA: | 27.65 | Buy |
50-day EMA: | 13.75 | Buy |
200-day EMA: | 3.86 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.19 | Sell |
20-day SMA: | 38.04 | Sell |
50-day SMA: | 37.88 | Sell |
200-day SMA: | 50 | Sell |
8-day EMA: | 35.96 | Sell |
20-day EMA: | 37.21 | Sell |
50-day EMA: | 38.25 | Sell |
200-day EMA: | 45.7 | Sell |
Global X Intermediate-Term Trsy Lddr ETF Earnings Growth & MLDR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.
Global X Intermediate-Term Trsy Lddr ETF Technical Analysis
Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|
Sep | |||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | |||||||||
8-day SMA: | |||||||||
20-day SMA: | |||||||||
50-day SMA: | |||||||||
200-day SMA: | |||||||||
8-day EMA: | |||||||||
20-day EMA: | |||||||||
50-day EMA: | |||||||||
200-day EMA: | |||||||||
MACD (12, 26): | |||||||||
Relative Strength Index (14 RSI): | |||||||||
Bollinger Bands (25): | |||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |